Loading...
Loading...
India's sitagliptin imports from PORTUGAL total $413 across 2 shipments from 1 foreign suppliers. PRIVAPOSERVICES GMBH leads with $413 in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include DR.REDDY'S LABORATORIES LTD. This corridor reflects India's pharmaceutical import demand for sitagliptin โ a concentrated sourcing relationship with select suppliers from PORTUGAL.

PRIVAPOSERVICES GMBH is the leading Sitagliptin supplier from PORTUGAL to India, with import value of $413 across 2 shipments. The top 5 suppliers โ PRIVAPOSERVICES GMBH โ collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) ยท Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | PRIVAPOSERVICES GMBH | $413 | 2 | 100.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | DR.REDDY'S LABORATORIES LTD | $413 | 2 | 100.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Sitagliptin suppliers from PORTUGAL to India include PRIVAPOSERVICES GMBH. The leading supplier is PRIVAPOSERVICES GMBH with import value of $413 USD across 2 shipments. India imported Sitagliptin worth $413 USD from PORTUGAL in total across 2 shipments.
India imported Sitagliptin worth $413 USD from PORTUGAL across 2 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Sitagliptin sourced from PORTUGAL include DR.REDDY'S LABORATORIES LTD. The largest buyer is DR.REDDY'S LABORATORIES LTD with $413 in imports across 2 shipments.
The total value of Sitagliptin imports from PORTUGAL to India is $413 USD, across 2 shipments and 1 foreign suppliers. Data source: Indian Customs (DGFT).
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records โ the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
2 Verified Shipments
1 suppliers, 1 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists